Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Cooper

Showing results (141-150 of 245) with videos related to

Pageof 25
Sort By:
Cancer|March 1, 1993
Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B studyJ J Kirshner, J R Anderson, B Parker, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Chemotherapy versus observation in high-risk node-negative breast cancer patientsE G Mansour, L Eudey, D C Tormey, et al.
Cancer|October 15, 1990
The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patientsT E Kute, H B Muss, M R Cooper, et al.
The New England Journal of Medicine|February 23, 1989
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup studyE G Mansour, R Gray, A H Shatila, et al.
Cancer|November 1, 1979
Combination chemotherapy of advanced non-oat cell carcinoma of the lungF Richards, D R White, H B Muss, et al.
Cancer Treatment Reports|July 1, 1978
Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized studyW L Ramseur, F Richards, H B Muss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B studyM R Cooper, K Dear, O R McIntyre, et al.
Cancer|November 1, 1978
Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trialH B Muss, D R White, F Richards, et al.
Cancer|November 1, 1982
Nonseminomatous germ cell cancer of the testis. Reducing treatment-related morbidity in patients with disseminated diseaseB R Paschal, H B Muss, F Richards, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group BN J Vogelzang, M Goutsou, J M Corson, et al.
Pageof 25

Showing results (141-150 of 245) with videos related to

Sort By:
Pageof 25
Cancer|March 1, 1993
Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B studyJ J Kirshner, J R Anderson, B Parker, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Chemotherapy versus observation in high-risk node-negative breast cancer patientsE G Mansour, L Eudey, D C Tormey, et al.
Cancer|October 15, 1990
The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patientsT E Kute, H B Muss, M R Cooper, et al.
The New England Journal of Medicine|February 23, 1989
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup studyE G Mansour, R Gray, A H Shatila, et al.
Cancer|November 1, 1979
Combination chemotherapy of advanced non-oat cell carcinoma of the lungF Richards, D R White, H B Muss, et al.
Cancer Treatment Reports|July 1, 1978
Chemoimmunotherapy for disseminated malignant melanoma: a prospective randomized studyW L Ramseur, F Richards, H B Muss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B studyM R Cooper, K Dear, O R McIntyre, et al.
Cancer|November 1, 1978
Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trialH B Muss, D R White, F Richards, et al.
Cancer|November 1, 1982
Nonseminomatous germ cell cancer of the testis. Reducing treatment-related morbidity in patients with disseminated diseaseB R Paschal, H B Muss, F Richards, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group BN J Vogelzang, M Goutsou, J M Corson, et al.
Pageof 25